uniQure N.V. (QURE) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Unicure second quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Chiara Russo, Senior Director of Investor Relations. Please go ahead. Good morning, and thank you for joining us for Unicare's second quarter of 2025 earnings call. Earlier this morning, Unicare released its financial results for the second quarter of 2025, and our press release is available on the Investors and Media section of our website, at unicare.com. Our 10Q was also filed with the SEC earlier this morning. Joining me on the call today are Matt Kavista, Chief Executive Officer, Dr. Walid Abisab, Chief Medical Officer, and Christian Klempt, Chief Financial Officer. After our formal remarks, we will open up the call for Q&A. Before we begin, Please know that we will be making forward-looking statements during this investor call. All statements other than statements of historical fact are forward-looking statements. They are based on management's beliefs and assumptions and on information available to management only as of the date of this conference call. Their actual results could differ maturely from those anticipated in these forward-looking statements for many reasons, including, without limitation, the factors described in UNICARE's most recent SEC filings. Given these risks, y...